161 related articles for article (PubMed ID: 15583090)
1. Lessons learned from a clinical trial.
Armstrong PW; Newby LK; Granger CB; Lee KL; Simes RJ; Van de Werf F; White HD; Califf RM;
Circulation; 2004 Dec; 110(23):3610-4. PubMed ID: 15583090
[No Abstract] [Full Text] [Related]
2. How hot is inflammation in acute coronary syndrome?
Verheugt FW
Eur Heart J; 2000 Dec; 21(24):1990-2. PubMed ID: 11102246
[No Abstract] [Full Text] [Related]
3. The evolving role of glycoprotein IIb/IIIa inhibitor therapy in contemporary care of acute coronary syndrome patients.
Tricoci P; Peterson ED
J Interv Cardiol; 2006 Oct; 19(5):449-55. PubMed ID: 17020570
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet agents and arterial thrombosis.
Billett HH
Cardiol Clin; 2008 May; 26(2):189-201, vi. PubMed ID: 18406994
[TBL] [Abstract][Full Text] [Related]
5. Early clinical results with the new oral glycoprotein IIb/IIIa agents.
Teirstein PS
Am J Cardiol; 1999 May; 83(9A):12E-15E. PubMed ID: 10357576
[No Abstract] [Full Text] [Related]
6. Optimizing antiplatelet therapy for the ACS patient: reacting to clinical trial data from the ISAR-REACT-2 studies.
Steinhubl SR
Rev Cardiovasc Med; 2006; 7 Suppl 4():S12-9. PubMed ID: 17224886
[TBL] [Abstract][Full Text] [Related]
7. Current antiplatelet therapies: benefits and limitations.
Angiolillo DJ; Guzman LA; Bass TA
Am Heart J; 2008 Aug; 156(2 Suppl):S3-9. PubMed ID: 18657680
[TBL] [Abstract][Full Text] [Related]
8. [ASS plus dipyridamole or clopidogrel after stroke: what is the best secondary prevention?].
Einecke D
MMW Fortschr Med; 2008 May; 150(21):6-7. PubMed ID: 18575244
[No Abstract] [Full Text] [Related]
9. [Secondary stroke prevention according to the PRoFESS Study. What are the sequelae for practical therapy?].
Diener C
MMW Fortschr Med; 2008 May; 150(21):7. PubMed ID: 18578065
[No Abstract] [Full Text] [Related]
10. The emerging role of platelet glycoprotein IIb/IIIa inhibitors in managing high-risk patients with non-ST segment elevation acute coronary syndromes.
Bolognese L
Curr Med Res Opin; 2007 Jun; 23(6):1217-26. PubMed ID: 17559721
[TBL] [Abstract][Full Text] [Related]
11. Controversies surrounding platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention and acute coronary syndromes.
Harrington RA
Semin Thromb Hemost; 2004 Dec; 30(6):639-47. PubMed ID: 15630670
[TBL] [Abstract][Full Text] [Related]
12. GPIIb/IIIa inhibitor-induced dethrombosis.
Furman MI; Frelinger AL; Michelson AD
J Thromb Thrombolysis; 2004 Aug; 18(1):11-7. PubMed ID: 15744548
[TBL] [Abstract][Full Text] [Related]
13. Rebound platelet activation after termination of prasugrel and aspirin therapy due to confirmed non-compliance in patient enrolled in the JUMBO Trial.
Serebruany VL; Midei MG; Meilman H; Malinin AI; Lowry DR
Int J Clin Pract; 2006 Jul; 60(7):863-6. PubMed ID: 16846403
[TBL] [Abstract][Full Text] [Related]
14. Letter regarding article by Hlatky et al, "medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease".
Osman F; Qaisar S; Pitt M
Circulation; 2005 Apr; 111(13):e176-7; author reply e176-7. PubMed ID: 15811864
[No Abstract] [Full Text] [Related]
15. [Combination of acetylsalicylic acid with dipyridamole is better than acetylsalicylic acid monotherapy].
Schindler B
Med Monatsschr Pharm; 2006 Nov; 29(11):421-3. PubMed ID: 17131692
[No Abstract] [Full Text] [Related]
16. Controversies of oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention.
Rajagopal V; Bhatt DL
Semin Thromb Hemost; 2004 Dec; 30(6):649-55. PubMed ID: 15630671
[TBL] [Abstract][Full Text] [Related]
17. Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study.
Savonitto S; Ambrosini V; Marzocchi A; Tolaro S; Petronio AS; Galassi AR; Bongo AS; Gaglione A; Bolognese L; ;
Ital Heart J; 2005 Feb; 6(2):106-18. PubMed ID: 15819503
[TBL] [Abstract][Full Text] [Related]
18. Randomisation in the SYMPHONY trial.
Altman DG
Lancet; 2000 Oct; 356(9240):1521-2. PubMed ID: 11081555
[No Abstract] [Full Text] [Related]
19. Platelet activation and progression to complications.
Kereiakes DJ; Michelson AD
Rev Cardiovasc Med; 2006; 7(2):75-81. PubMed ID: 16915126
[TBL] [Abstract][Full Text] [Related]
20. The independent statistician for data monitoring committees.
DeMets DL; Fleming TR
Stat Med; 2004 May; 23(10):1513-7. PubMed ID: 15122729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
